A New Era of Medicine

Gyroscope was founded to explore the convergence of advancements made in the understanding of the complement system’s impact on eye disease, the genetic basis of Age-related Macular Degeneration (AMD) and gene therapy as a mode of sustained treatment delivery.

An unmet medical need

Age-related Macular Degeneration is the leading cause of irreversible blindness in the elderly.

Today there is no effective treatment for the atrophic form of the disease

Science advancements

We better understand the genetic basis of age-related macular degeneration (AMD) and the role that the complement system plays in AMD progression.

Gyroscope Therapeutics aims at developing effective treatments for AMD

Gyroscope is an ophthalmology company developing cutting edge, genetically-defined therapies for the treatment of eye diseases linked to an unbalanced complement system.